Abiopharma

🔍 TAUTGES JOSEPH A (Executive)

Company: Ambiq Micro, Inc. (AMBQ)

Report Date: 2026-06-08

Detailed Transactions and Holdings:

• Acquired 4,957 shares of Common Stock (Direct)
  Date: 2026-06-08 | Code: A | equity_swap_involved: 0 | shares_owned_after: 53,703.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in three equal annual installments following the date of grant, with each annual RSU vesting to occur on the earlier of: (i) the first, second, or third anniversary of the grant date, as applicable, or (ii) the date of the Company's first, second, or third annual stockholder meeting following the grant date, as applicable (or the date immediately prior to the applicable annual stockholder meeting if the Reporting Person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election), subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2025 Equity Incentive Plan).